Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $121,054 | 1 | 99.2% |
| Consulting Fee | $500.00 | 1 | 0.4% |
| Food and Beverage | $458.02 | 15 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $121,054 | 1 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $628.45 | 6 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $139.37 | 2 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $84.03 | 5 | $0 (2018) |
| US WorldMeds, LLC | $78.57 | 1 | $0 (2017) |
| ABBVIE INC. | $17.22 | 1 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $10.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $17.22 | 1 | ABBVIE INC. ($17.22) |
| 2019 | $121,054 | 1 | Allergan Inc. ($121,054) |
| 2018 | $35.46 | 2 | Supernus Pharmaceuticals, Inc. ($35.46) |
| 2017 | $905.34 | 13 | Teva Pharmaceuticals USA, Inc. ($628.45) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/30/2019 | Allergan Inc. | BOTOX (Biological) | Gift | Cash or cash equivalent | $121,054.06 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/30/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: AED | ||||||
| 07/31/2018 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: AED | ||||||
| 10/29/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: Central Nervous System | ||||||
| 10/24/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: AED | ||||||
| 09/17/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Central Nervous System | ||||||
| 09/17/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: Central Nervous System | ||||||
| 08/06/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Central Nervous System | ||||||
| 07/11/2017 | US WorldMeds, LLC | Xadago (Drug), APOKYN, MYOBLOC | Food and Beverage | In-kind items and services | $78.57 | General |
| Category: Neurology | ||||||
| 06/27/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: AED | ||||||
| 06/19/2017 | Teva Pharmaceuticals USA, Inc. | SD809-HD (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Central Nervous System | ||||||
| 06/19/2017 | Teva Pharmaceuticals USA, Inc. | SD809-HD (Drug) | Food and Beverage | In-kind items and services | $105.12 | General |
| Category: Central Nervous System | ||||||
| 06/07/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $118.04 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2017 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: AED | ||||||
| 01/12/2017 | Ipsen Biopharmaceuticals, Inc | Dysport 300 U-1 (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Neurology | ||||||
About Dr. Lee Tempel, MD
Dr. Lee Tempel, MD is a Internal Medicine healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306874144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lee Tempel, MD has received a total of $122,012 in payments from pharmaceutical and medical device companies, with $17.22 received in 2022. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Gift" ($121,054).
Practice Information
- Specialty Internal Medicine
- Other Specialties Neurology
- Location Saint Louis, MO
- Active Since 06/29/2006
- Last Updated 07/21/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306874144
Products in Payments
- BOTOX (Biological) $121,071
- SD809-HD (Drug) $605.12
- GILENYA (Drug) $139.37
- Xadago (Drug) $78.57
- TROKENDI XR (Drug) $51.19
- OXTELLAR XR (Drug) $32.84
- SD809-TD (Drug) $16.19
- Dysport 300 U-1 (Drug) $10.38
- COPAXONE (Drug) $7.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Saint Louis
Dr. John Lasala, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Mark Fesler, Md, MD
Internal Medicine — Payments: $700,896
Dr. Katie Schroeder, Md, MD
Internal Medicine — Payments: $659,683
Edward Charbek, Md, MD
Internal Medicine — Payments: $260,967
Dr. Michael Reschak, M.d, M.D
Internal Medicine — Payments: $245,910
Dr. Osler Jay Guzon, Md, MD
Internal Medicine — Payments: $237,841